The Impact of a Pharmacist-led Educational Interview on Medication Adherence of Saudi Patients with Epilepsy

Overview

Journal Patient Prefer Adherence

Date 2017 Jun 3

PMID 28572723

Citations 8

Authors

Refah AlAjmi

Sinaa Al-Aqeel

Salah Baz

Affiliations

Soon will be listed here.

Abstract

Purpose: To evaluate the effectiveness of a pharmacist-led educational interview in terms of adherence to antiepileptic drug administration among adult patients with epilepsy.

Method: Sixty adult patients with epilepsy who fulfilled the inclusion criteria were recruited. A pharmacist-led educational interview was conducted with the intervention group (n=30). Patients in the control group (n=30) were interviewed and contacted 6 weeks after the initial visit without receiving any intervention. Antiepileptic drug adherence was measured during clinic visits, and 6 weeks afterwards using the 8-item Morisky Medication Adherence Scale. This prospective interventional study was conducted between September and December 2013.

Results: Only 29 control patients and 27 intervention patients completed the 6 weeks post-intervention adherence measurement. The adherence score average in the intervention group was 5.26±0.98 at baseline and improved to 6.7±0.823 (<0.0001) after intervention. In the control group, the adherence score average was 5.76±1.806 at baseline and 5.83±1.627 at 6 weeks (=0.792). While there was no statistically significant difference in adherence score between intervention and control groups at baseline, the post-intervention difference was significant (=0.024).

Conclusion: Our study suggests that pharmacist-led educational interviews had a positive impact on medication adherence in patients with epilepsy.

Citing Articles

The Role of Pharmacists' Interventions in Increasing Medication Adherence of Patients With Epilepsy: A Scoping Review.

Ernawati I, Yasin N, Setyopranoto I, Ikawati Z J Prev Med Public Health. 2024; 57(3):212-222.

PMID: 38697913 PMC: 11164599. DOI: 10.3961/jpmph.23.592.

Pharmacist's Impact on Medication Adherence and Drug-Related Problems in Patients with Epilepsy.

Ozdag E, Firat O, Coban Taskin A, Uludag I, Sener U, Demirkan K Turk J Pharm Sci. 2024; 20(6):361-367.

PMID: 38254332 PMC: 10803922. DOI: 10.4274/tjps.galenos.2023.36080.

Opportunities for Community Pharmacists to Counsel Patients With Epilepsy and Seizure Clusters to Overcome Barriers and Foster Appropriate Treatment.

Gidal B, Welty T, Cokley J, Farrell M, Shafer P, Rabinowicz A J Pharm Pract. 2022; 37(1):190-197.

PMID: 36193947 PMC: 10804691. DOI: 10.1177/08971900221126570.

The Role of Clinical Pharmacist in Pediatrics' Adherence to Antiepileptic Drugs.

Jarad S, Akour A, Khreisat W, Elshammari A, Madaeen S J Pharm Technol. 2022; 38(5):272-282.

PMID: 36046350 PMC: 9420919. DOI: 10.1177/87551225221097619.

Impact of Physical Activity and Medication Adherence on the Seizure Frequency and Quality of Life of Epileptic Patients: A Population Study in West Texas.

Lee Y, Ahn Y, Cucullo L Biomed Res Int. 2022; 2022:4193664.

PMID: 35087908 PMC: 8789420. DOI: 10.1155/2022/4193664.

References

Faught R, Weiner J, Guerin A, Cunnington M, Duh M . Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia. 2009; 50(3):501-9. DOI: 10.1111/j.1528-1167.2008.01794.x. View

DiIorio C, Bamps Y, Walker E, Escoffery C . Results of a research study evaluating WebEase, an online epilepsy self-management program. Epilepsy Behav. 2011; 22(3):469-74. DOI: 10.1016/j.yebeh.2011.07.030. View

Tang F, Zhu G, Jiao Z, Ma C, Chen N, Wang B . The effects of medication education and behavioral intervention on Chinese patients with epilepsy. Epilepsy Behav. 2014; 37:157-64. DOI: 10.1016/j.yebeh.2014.05.017. View

Dash D, Sebastian T, Aggarwal M, Tripathi M . Impact of health education on drug adherence and self-care in people with epilepsy with low education. Epilepsy Behav. 2015; 44:213-7. DOI: 10.1016/j.yebeh.2014.12.030. View

Al-Aqeel S, Gershuni O, Al-Sabhan J, Hiligsmann M . Strategies for improving adherence to antiepileptic drug treatment in people with epilepsy. Cochrane Database Syst Rev. 2017; 2:CD008312. PMC: 6464338. DOI: 10.1002/14651858.CD008312.pub3. View

Krousel-Wood M, Islam T, Webber L, Re R, Morisky D, Muntner P . New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009; 15(1):59-66. PMC: 2728593. View

Costa E, Giardini A, Savin M, Menditto E, Lehane E, Laosa O . Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence. 2015; 9:1303-14. PMC: 4576894. DOI: 10.2147/PPA.S87551. View

Ngugi A, Kariuki S, Bottomley C, Kleinschmidt I, Sander J, Newton C . Incidence of epilepsy: a systematic review and meta-analysis. Neurology. 2011; 77(10):1005-12. PMC: 3171955. DOI: 10.1212/WNL.0b013e31822cfc90. View

Molugulu N, Gubbiyappa K, Vasudeva Murthy C, Lumae L, Mruthyunjaya A . Evaluation of self-reported medication adherence and its associated factors among epilepsy patients in Hospital Kuala Lumpur. J Basic Clin Pharm. 2016; 7(4):105-109. PMC: 5153886. DOI: 10.4103/0976-0105.189430. View

10.

Fisher R, van Emde Boas W, Blume W, Elger C, Genton P, Lee P . Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005; 46(4):470-2. DOI: 10.1111/j.0013-9580.2005.66104.x. View

11.

Long L, REEVES A, Moore J, Roach J, Pickering C . An assessment of epilepsy patients' knowledge of their disorder. Epilepsia. 2000; 41(6):727-31. DOI: 10.1111/j.1528-1157.2000.tb00235.x. View

12.

Sweileh W, Ihbesheh M, Jarar I, Taha A, Sawalha A, Zyoud S . Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav. 2011; 21(3):301-5. DOI: 10.1016/j.yebeh.2011.04.011. View

13.

Peterson G, McLean S, MILLINGEN K . A randomised trial of strategies to improve patient compliance with anticonvulsant therapy. Epilepsia. 1984; 25(4):412-7. DOI: 10.1111/j.1528-1157.1984.tb03436.x. View

14.

. ASHP guidelines on pharmacist-conducted patient education and counseling. Am J Health Syst Pharm. 1997; 54(4):431-4. DOI: 10.1093/ajhp/54.4.431. View

15.

Simon-Tuval T, Neumann P, Greenberg D . Cost-effectiveness of adherence-enhancing interventions: a systematic review. Expert Rev Pharmacoecon Outcomes Res. 2016; 16(1):67-84. DOI: 10.1586/14737167.2016.1138858. View

16.

Al-Jumah K, Qureshi N . Impact of pharmacist interventions on patients' adherence to antidepressants and patient-reported outcomes: a systematic review. Patient Prefer Adherence. 2012; 6:87-100. PMC: 3277799. DOI: 10.2147/PPA.S27436. View

17.

Ferrari C, de Sousa R, Castro L . Factors associated with treatment non-adherence in patients with epilepsy in Brazil. Seizure. 2013; 22(5):384-9. DOI: 10.1016/j.seizure.2013.02.006. View

18.

Morisky D, DiMatteo M . Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2010; 64(3):255-7. PMC: 3109729. DOI: 10.1016/j.jclinepi.2010.09.002. View

19.

Stirratt M, Dunbar-Jacob J, Crane H, Simoni J, Czajkowski S, Hilliard M . Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015; 5(4):470-82. PMC: 4656225. DOI: 10.1007/s13142-015-0315-2. View

20.

Paschal A, Rush S, Sadler T . Factors associated with medication adherence in patients with epilepsy and recommendations for improvement. Epilepsy Behav. 2013; 31:346-50. DOI: 10.1016/j.yebeh.2013.10.002. View